![[H] New drug class unveiled at Imperial](/uploads/r/null/5/c/f/5cfe2690a75dea3d88e949f10bd235d53444a6cabf876c79e0c08c96e5d7dbc9/31ab3491-82f2-4f10-93f0-74d5656df0b7-_H__screencapture-englemed-co-uk-18-18apr111-tumour-new-drug-class-php-2020-12-01-08_48_01_142.jpg)
News story on New cancer drug class unveiled at Imperial
Sans titre![[I] Evotec Partnered Drug Discovery and Development](/uploads/r/null/1/e/2/1e212d9538459860906f8031c85645193d90ba79f8a7e41367f0fd2e6d0ff2ca/1b81052e-6d69-4cf0-867c-91a0648f85d6-_I__Evotec_SE_142.jpg)
Company Presentation featuring CT7001 on slide 19
Sans titre![[C] Using wood waste to produce biochemicals: Green chemistry for a green future.](/uploads/r/null/e/7/7/e77a858f961d3d3dfc4025dadf0491c601776a29f5d1d53e28741e6d64265984/c5459d40-7f5f-451b-b734-396d8611c930-_C__screencapture-thechemicalengineer-features-using-wood-waste-to-produce-biochemicals-green-chemistry-for-a-green-future-2021-03-02-09_21_13_142.jpg)
Feature on using wood waste to produce biochemical and impact of this
Sans titre![[E] RFC Power secures seed investment to develop the world’s lowest cost flow battery](/uploads/r/null/a/7/d/a7dc050f8693d671927407337667aa2d5fe222ea1393c87c82f1cbf215055bb4/e573794a-7fa7-43fa-90be-ff6e46004862-_E__screencapture-ipgroupplc-media-portfolio-news-2020-2020-01-21-2021-03-02-09_26_43_142.jpg)
RFC Power seed investment to develop lowest cost flow battery
![[F] SweetGen: abiotic wastewater fuel cell](/uploads/r/null/4/5/0/45038773f0a32fbcabbcda6a181f051d4acb133408176f20c013fe64c391dab9/992543b7-003f-4835-9016-19218967da2e-_F__screencapture-rsc-org-competitions-emerging-technologies-case-studies-sweetgen-2021-03-02-09_30_35_142.jpg)
Feature on SweetGen
![[G] Better Future. A Route Map to Creating a Cleantech Cluster in London.](/uploads/r/null/8/9/8/898e40b51c22b556b0cce111cc9ebd473c9a7ff2fde0b544368ce192d9659585/6a459c2e-d266-4898-9b1d-09160128308f-_G__lsdc_-_better_future_report_2016_142.jpg)
Report from the London Sustainable Development Commission (LSDC) - A route map creating a Cleantech cluster in London
![[I] The London Plan. Mayor of London.](/uploads/r/null/7/a/7/7a76ce18af41200a53fcec82d37c867e4b0aa2d2b50867c03fb1b837b3a84fb6/70a7dcab-e952-4b45-afab-3e0fc19fd04d-_I__new_london_plan_december_2017_142.jpg)
The London Plan
![[B] Bramble Energy Press Coverage](/uploads/r/null/5/f/2/5f2d08b4b8d800dd61a9fcb4d5e7c4a3f5b6d41dbee0af63af10f4a850ad67c5/07ddab9c-8aa7-4036-9749-689480a766a2-_B__Bramble_Energy_Press_Coverage_142.jpg)
Coverage by The Telegraph (Monday 3 August 2020), The Telegraph (19 October 2019) and Sunday Times (27 December 2020)
![[C] ZOT - Fuel Cell Manufacturing](/uploads/r/null/d/5/5/d55b8676f3b8f35c0a6a59c3fe37f7bad91914e2694a2b093fa3b76dc70aebbf/9d9c5ce2-f101-439c-bee8-a426b4b127cf-_C__zot-co-uk-newsitem-php-2021-02-05-17_37_47_142.jpg)
News story on the start of fuel cell manufacturing by ZOT
Sans titre![[B] Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer.](/uploads/r/null/f/1/b/f1bd1623cdf41cc526be4879eec4c7d5a7795f046a66b1da207ebec998b32ce6/65f52ff2-086d-491e-a3d1-110b8ccf5f1c-_B__screencapture-bloomberg-press-releases-2020-11-16-myricx-pharma-2021-03-05-09_21_38_142.jpg)
Press release for Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer
![[E] Funding to Vidya Health for Saliva Diagnostics. NHS Health Research Authority.](/uploads/r/null/2/8/5/2850997dbc1a7c6f00e426fda5c34b7e9a97045a57eed4f5e252217895ad0e66/451f1af3-c518-4ac8-9e12-9fc4f903103e-_E__screencapture-hra-nhs-uk-planning-and-improving-research-application-summaries-research-summaries-saliva-diagnostics-2021-03-02-09_59_54_142.jpg)
Funding to Vidya Health for Saliva Diagnostics. NHS Health Research Authority
Sans titre![[G] Amazon sales page of BioMin toothpaste](/uploads/r/null/e/b/d/ebd69e569a57017d93b3948c6f95ebe5d43847552ef58aa13664225b935381fa/1908963a-db38-4229-8c50-bb5f8a257945-_G__screencapture-amazon-co-uk-toothpaste-EasyPick-support-remineralisation-cleaning-dp-B01N901QRD-2021-03-02-10_07_33_142.jpg)
![[I] BioMin receives FDA Approval](/uploads/r/null/e/0/d/e0d10257e5ce4513c24779a688d480921b2a63732d8c13cba6b66e4e807038e6/da5393f2-0a6e-42d0-8c99-528523bf89cf-_I__screencapture-markets-businessinsider-news-stocks-dr-collins-biomin-toothpaste-receives-fda-approval-1028470492-2021-03-05-09_24_47_142.jpg)
Press release stating that Dr.Collins BioMin Toothpaste Receives FDA Approval
Sans titre![[E] Drax and Econic partner to produce plastic using waste CO2](/uploads/r/null/0/8/8/088840ba4bcf8e200d47d664d449fcc442ccf989b44e3af7ee2ea15db6129f02/2b0b06e4-9c45-4dca-8854-90d4e911ee0a-_E__thechemicalengineer-news-drax-and-econic-partner-2020-08-26-15_35_03_142.jpg)
![[I] Press coverage of Econic](/uploads/r/null/a/8/7/a8752998fb1114c3d4a66fd1489a9aaf49e8f82acd46686133f4660978b76200/7dfd68b4-61db-42fd-89a8-87a9c44e481d-_I__Econic_Press_Coverage_142.jpg)
Press coverage from the BBC, Telegraph, The Times, New Scientist
![[G] CT7001, a Novel Orally Bio-Available CDK7 Inhibitor, Is Highly Active in in-Vitro and in-Vivo Models of AML](/uploads/r/null/9/8/f/98f0be0cc74976d6172fdfef26146097b9e6cf93bddfe925ff86c5ab602b551e/613e972b-13ae-4ef0-abd2-fb7eaa3af5a9-_G__ashpublications-org-blood-article-2020-08-27-15_19_51_142.jpg)
Early results from CT7001
![[A] Scientists set sights on biomass to reduce fossil fuel dependence. Phys Org](/uploads/r/null/b/5/3/b5306978cd54d8585cf57fedcc8f7eb2632536610900e898bd9869d81f47c3f8/ce8ace64-03d6-4ad3-8cee-b59d656f824a-_A__screencapture-phys-org-news-2006-01-scientists-sights-biomass-fossil-fuel-html-2021-03-05-16_51_22_142.jpg)
Story on the formation of the AtlantIC Alliance and Science paper
![[H] Mayor of London, About Better Futures](/uploads/r/null/9/0/b/90beb2f42213c1e4ccd8aa69e998f9d12ddc94919cc6cb1ced999b069f03b14a/2c04975e-9dd9-4069-9ca0-9b164478b560-_H__screencapture-london-gov-uk-what-we-do-environment-better-futures-about-better-futures-2021-03-02-09_33_55_142.jpg)
Press Release on the Better Futures plan for London